Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Holst Wolff

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Biomedical Science|October 8, 2022
Delivering genes with human immunodeficiency virus-derived vehicles: still state-of-the-art after 25 yearsJonas Holst Wolff, Jacob Giehm Mikkelsen
Frontiers in Genome Editing|March 27, 2023
Prime editing in hematopoietic stem cells-From <i>ex vivo</i> to <i>in vivo</i> CRISPR-based treatment of blood disordersJonas Holst Wolff, Jacob Giehm Mikkelsen
Frontiers in Genome Editing|December 6, 2021
piggyPrime: High-Efficacy Prime Editing in Human Cells Using piggyBac-Based DNA TranspositionJonas Holst Wolff, Jakob Haldrup, Emil Aagaard Thomsen, et al.
Nucleic Acids Research|June 1, 2021
pegIT - a web-based design tool for prime editingMads Valdemar Anderson, Jakob Haldrup, Emil Aagaard Thomsen, et al.
Nucleic Acids Research|August 14, 2025
Gene editing in hematopoietic stem cells by co-delivery of Cas9/sgRNA ribonucleoprotein and templates for homology-directed repair in 'all-in-one' lentivirus-derived nanoparticlesSofie Andersen, Jonas Holst Wolff, Thomas Wisbech Skov, et al.
Nucleic Acids Research|September 7, 2023
Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modificationJakob Haldrup, Sofie Andersen, Alexander Rafael LaVilla Labial, et al.
Nature Communications|August 12, 2025
Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous diseaseJonas Holst Wolff, Thomas Wisbech Skov, Didde Haslund, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2025
Treatment of GATA2 deficiency by allele-specific CRISPR-Cas9-directed gene correction in hematopoietic stem cellsThomas Wisbech Skov, Jonas Holst Wolff, Didde Haslund, et al.
Molecular Therapy. Advances|July 13, 2026
AAV vector production in suspension cells using PEI transfection and sodium butyrate with orthogonal assessment of function and qualitySujan Ravendran, Simon Fammé, Maya Graham Noer, et al.
The Journal of Experimental Medicine|October 29, 2025
Genetically heterozygous - transcriptionally homozygous IRF7 deficiency underlies herpesvirus CNS infections in humansMarvin Werner, Jonas Holst Wolff, Justin Taft, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Biomedical Science|October 8, 2022
Delivering genes with human immunodeficiency virus-derived vehicles: still state-of-the-art after 25 yearsJonas Holst Wolff, Jacob Giehm Mikkelsen
Frontiers in Genome Editing|March 27, 2023
Prime editing in hematopoietic stem cells-From <i>ex vivo</i> to <i>in vivo</i> CRISPR-based treatment of blood disordersJonas Holst Wolff, Jacob Giehm Mikkelsen
Frontiers in Genome Editing|December 6, 2021
piggyPrime: High-Efficacy Prime Editing in Human Cells Using piggyBac-Based DNA TranspositionJonas Holst Wolff, Jakob Haldrup, Emil Aagaard Thomsen, et al.
Nucleic Acids Research|June 1, 2021
pegIT - a web-based design tool for prime editingMads Valdemar Anderson, Jakob Haldrup, Emil Aagaard Thomsen, et al.
Nucleic Acids Research|August 14, 2025
Gene editing in hematopoietic stem cells by co-delivery of Cas9/sgRNA ribonucleoprotein and templates for homology-directed repair in 'all-in-one' lentivirus-derived nanoparticlesSofie Andersen, Jonas Holst Wolff, Thomas Wisbech Skov, et al.
Nucleic Acids Research|September 7, 2023
Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modificationJakob Haldrup, Sofie Andersen, Alexander Rafael LaVilla Labial, et al.
Nature Communications|August 12, 2025
Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous diseaseJonas Holst Wolff, Thomas Wisbech Skov, Didde Haslund, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2025
Treatment of GATA2 deficiency by allele-specific CRISPR-Cas9-directed gene correction in hematopoietic stem cellsThomas Wisbech Skov, Jonas Holst Wolff, Didde Haslund, et al.
Molecular Therapy. Advances|July 13, 2026
AAV vector production in suspension cells using PEI transfection and sodium butyrate with orthogonal assessment of function and qualitySujan Ravendran, Simon Fammé, Maya Graham Noer, et al.
The Journal of Experimental Medicine|October 29, 2025
Genetically heterozygous - transcriptionally homozygous IRF7 deficiency underlies herpesvirus CNS infections in humansMarvin Werner, Jonas Holst Wolff, Justin Taft, et al.
Pageof 1